EURneffy (neffy® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children (>30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights to ...
People suffering from migraines will soon have access to pain relief in the form of a nasal spray. The U.S. Food and Drug Administration (FDA) has approved the first calcitonin gene-related peptide ...
People suffering from migraines will soon have access to pain relief in the form of a nasal spray. The U.S. Food and Drug Administration (FDA) has approved the first calcitonin gene-related peptide ...
EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head ...
Altamira Therapeutics Announces Certification of Bentrio Nasal Spray under Medical Device Regulation
Conformity with stringent new EU regulations for medical devices confirmedAllows for commercialization of Bentrio in EU member states; facilitates regulatory approval in various other countriesMajor ...
Please provide your email address to receive an email when new articles are posted on . The FDA has extended the prescription drug user fee act target action date for the new drug application for ...
A recall has been issued for Walgreens Saline Nasal Spray with xylitol, due to concerns about bacterial contamination, ...
The MarketWatch News Department was not involved in the creation of this content. -- SWIFT-1 and -2 trials showed depemokimab reduced exacerbation and hospitalization rates as an add-on therapy for ...
The U.S. Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults.The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback